No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Radiopharm Theranostics Presents Positive Data for RAD202 Antibody
ADRs End Higher; Radiopharm Theranostics Ltd. Climbs 28%
Radiopharm Theranostics Ltd: Half Year Report and Appendix 4D 31 December 2024
Radiopharm Theranostics Says Its Proprietary Radiotracer Detected Brain Metastases in New Clinical Study; Shares Down 4%
Radiopharm Theranostics Raises $5 Million Via Private Placement to Lantheus, Shares Surge 58%
ASX Biggest Gainers